Western Michigan University Homer Stryker M.d. School Of Medicine

Western Michigan University Homer Stryker M.D. School of Medicine, doing business as Western View, is a private nonprofit medical school in Kalamazoo, Michigan that delivers medical education, biomedical research, and forensic pathology services to federal agencies as a prime recipient of federal grants and a prime contractor under a single Navy basic ordering agreement (BOA). The institution competes on full-and-open terms across federal funding with no set-aside designations on its recent contracts or grants.

The school's customer concentration is heavily concentrated on the Department of the Navy's Bureau of Medicine and Surgery, which anchors 20 of 44 named prime contract awards (22 task orders under BOA N0018917GZ004) valued at $1.1 million in combined potential value — all delivery orders for medical student tuition and fees issued under the BOA with an ultimate completion date of December 31, 2026. Beyond Navy tuition contracts, the school's federal footprint splits between biomedical research grants and mission-specific federal support. The National Institutes of Health (through the National Institute of Allergy and Infectious Diseases) has funded seven prime research grants, while the National Institute on Drug Abuse, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute on Aging, and the National Institute of Neurological Disorders and Stroke have each funded research spanning immunology, orthopedic implant engineering, neurodegenerative disease, and aging. The Bureau of Justice Assistance has awarded six prime grants totaling support for forensic pathology fellowship training and medical examiner's office accreditation and operations; the school's medical examiner's office serves thirteen Michigan counties and has maintained National Association of Medical Examiners (NAME) accreditation since 2016. The Department of Health and Human Services has funded residency training in mental and behavioral health ($2.476942 million project grant awarded December 31, 2022, with completion through September 29, 2027). A single $25 thousand Army Forces Command purchase order (June 27, 2023 through June 26, 2024) covered trial consultation and travel services to support legal programs at Fort Stewart, Georgia.

Representative prime grant work includes a $570 thousand National Institute of Arthritis and Musculoskeletal and Skin Diseases research award (August 15, 2026 through July 31, 2029) for enhanced surface modifications of polyetheretherketone orthopedic implants; a $418 thousand National Institute on Aging grant (September 15, 2024 through August 31, 2026) investigating B cell immunology and aging-related neuroinflammation; a $342 thousand National Institute of Diabetes and Digestive and Kidney Diseases project grant (September 15, 2025 through August 31, 2027) developing cellular tools for polycystic kidney disease research; and a $145.054 thousand Bureau of Justice Assistance award (October 1, 2024 through September 30, 2027) supporting a forensic pathology fellowship program and accreditation maintenance.

Grant sub-award activity reflects the school's role in multi-institutional research consortia. Since early 2023, Western View has served as a sub-recipient under prime grants from Loyola University of Chicago (opioid and substance use disorder research), Van Andel Research Institute (epidemiological study design and patient recruitment across four WMed clinics), Michigan State University (first-episode psychosis clinical characterization), Regents of the University of Michigan (rural addiction medicine and hub-and-spoke model development), Dartmouth-Hitchcock Clinic (e-cigarette provision and behavioral smoking cessation research), Baylor College of Medicine (biomarker statistical evaluation), and the Michigan Department of State Police (crisis intervention training curriculum development). Additional sub-awards flow from the Michigan Department of Health and Human Services for toxicology reporting, opioid mortality investigation, and healthcare preparedness spanning 2023 through 2026.

The school's award portfolio shows stable research grant activity (7 awards in 2022, 8 in 2023, ramping to 16 in 2024 and 11 in 2025) supported by Navy tuition contracts that renew annually. Six awards (combined potential value $36 thousand) reach ultimate completion within the next twenty-four months, creating limited recompete exposure. Across 82 total awards tracked in the source (both prime and sub), the school has obligated $39.8 million against a combined potential value of $1.3 million, indicating substantial invoiced revenue against smaller contracted ceilings, a profile typical of multi-year research and education grants with amendments and budget authority adjustments.